Literature DB >> 35220467

Antimicrobial Resistance of Shigella flexneri in Pakistani Pediatric Population Reveals an Increased Trend of Third-Generation Cephalosporin Resistance.

Iqbal Nisa1, Mohammad Haroon2, Arnold Driessen3, Jeroen Nijland3, Hazir Rahman4, Nusrat Yasin1, Mubashir Hussain1, Taj Ali Khan1, Amjad Ali5, Saeed Ahmad Khan6, Muhammad Qasim7.   

Abstract

The rapid emergence of resistance to third-generation cephalosporins in Shigella flexneri is crucial in pediatric shigellosis management. Limited studies have been conducted on molecular pattern of antibiotic resistance of S. flexneri in diarrhea endemic areas of Pakistan. The aim of the study was to analyze the antimicrobial resistance of S. flexneri isolated from pediatric diarrheal patients in Peshawar, Pakistan. A total of 199 S. flexneri isolates (clinical, n = 1 55 and non-clinical, n = 44) were investigated for drug resistance and mutational analysis of selected drug resistance genes. All isolates were found to be highly resistant to amoxicillin/clavulanic acid (88%), followed by trimethoprim-sulfamethoxazole (77%), chloramphenicol (43%), and quinolones (41.6%). About 34.5% S. flexneri isolates were found to be resistant to third-generation cephalosporin. None of the isolates was resistant to imipenem, piperacillin-tazobactam, and amikacin. Interestingly high frequency of third-generation cephalosporin resistance was observed in S. flexneri isolated from non-clinical samples (49%) when compared to clinical samples (30.5%). Furthermore, the most prevalent phenotypic-resistant patterns among third-generation cephalosporin-resistant isolates were AMC,CAZ,CPD,CFM,CRO,SXT (13%) followed by OFX,AMC,CAZ,CPD,CFM,CRO,SXT,NA,CIP (10%). The most frequently detected resistance genes were trimethoprim-sulfamethoxazole (sul2 = 84%), beta-lactamase genes (blaOXA = 87%), quinolones (qnrS = 77%), and chloramphenicol (cat = 64%). No mutation was detected in any drug-resistant genes. We are reporting for the first time the sequence of the blaTEM gene in S. flexneri. Furthermore, high third-generation cephalosporin resistance was observed in the patients who practiced self-medication as compared to those who took medication according to physician prescription. This study shows the high emergence of third-generation cephalosporin-resistant S. flexneri isolates, which is a potential threat to the community in the country. This finding will be helpful to develop a suitable antibiotic prescription regime to treat shigellosis.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35220467     DOI: 10.1007/s00284-022-02805-9

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  37 in total

1.  Emergence of resistance to fluoroquinolones and third-generation cephalosporins in Shigella flexneri subserotype 1c isolates from China.

Authors:  S Qiu; X Xu; Y Wang; G Yang; Z Wang; H Wang; L Zhang; N Liu; C Chen; W Liu; J Li; W Su; L Jia; L Wang; H Jin; P Keim; Z Yuan; L Huang; H Song
Journal:  Clin Microbiol Infect       Date:  2012-02-13       Impact factor: 8.067

2.  SHV-type extended-spectrum beta-lactamase in a Shigella flexneri clinical isolate.

Authors:  N Fortineau; T Naas; O Gaillot; P Nordmann
Journal:  J Antimicrob Chemother       Date:  2001-05       Impact factor: 5.790

3.  Cephalosporin-resistant Shigella flexneri over 9 years (2001-09) in India.

Authors:  Neelam Taneja; Abhishek Mewara; Ajay Kumar; Garima Verma; Meera Sharma
Journal:  J Antimicrob Chemother       Date:  2012-03-12       Impact factor: 5.790

4.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Authors:  K L Kotloff; J P Winickoff; B Ivanoff; J D Clemens; D L Swerdlow; P J Sansonetti; G K Adak; M M Levine
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

5.  Trends in antimicrobial resistance in Shigella species in Karachi, Pakistan.

Authors:  Erum Khan; Kausar Jabeen; Muslima Ejaz; Jaweriah Siddiqui; Muhammad Farrukh Shezad; Afia Zafar
Journal:  J Infect Dev Ctries       Date:  2009-12-15       Impact factor: 0.968

6.  Global analysis of a plasmid-cured Shigella flexneri strain: new insights into the interaction between the chromosome and a virulence plasmid.

Authors:  Li Zhu; Xiankai Liu; Xuexue Zheng; Xin Bu; Ge Zhao; Chaohua Xie; Jingfei Zhang; Na Li; Erling Feng; Jie Wang; Yongqiang Jiang; Peitang Huang; Hengliang Wang
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

7.  Antimicrobial susceptibility pattern of Shigella spp. isolated from children under 5 years of age attending tertiary care hospitals, Nepal along with first finding of ESBL-production.

Authors:  Subhash Dhital; Jeevan Bahadur Sherchand; Bharat Mani Pokharel; Keshab Parajuli; Shyam Kumar Mishra; Sangita Sharma; Hari Prasad Kattel; Sundar Khadka; Sulochana Khatiwada; Basista Rijal
Journal:  BMC Res Notes       Date:  2017-06-05

8.  Multidrug-resistant Shigella infection in pediatric patients with diarrhea from central Iran.

Authors:  Elnaz Abbasi; Hamid Abtahi; Alex van Belkum; Ehsanollah Ghaznavi-Rad
Journal:  Infect Drug Resist       Date:  2019-06-07       Impact factor: 4.003

9.  Prevalence and trends of aminoglycoside resistance in Shigella worldwide, 1999-2010.

Authors:  Bing Gu; Xing Ke; Shiyang Pan; Yan Cao; Ling Zhuang; Rongbin Yu; Huimin Qian; Genyan Liu; Mingqing Tong
Journal:  J Biomed Res       Date:  2013-02-28

10.  Dominant serotype distribution and antimicrobial resistance profile of Shigella spp. in Xinjiang, China.

Authors:  Hongbo Liu; Binghua Zhu; Shaofu Qiu; Yidan Xia; Beibei Liang; Chaojie Yang; Nian Dong; Yongrui Li; Ying Xiang; Shan Wang; Jing Xie; Muti Mahe; Yansong Sun; Hongbin Song
Journal:  PLoS One       Date:  2018-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.